Clinical trial
Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
NCT07484607 is registered in ClinicalTrials.gov with Alexander Horsley as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
- Lead sponsor
- Alexander Horsley
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- October 9, 2025
- Completion date
- December 31, 2029
- Enrollment
- 200 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cystic fibrosis (cf), cystic fibrosis pulmonary exacerbation